FluidForm Bio
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
283 Bear Hill Rd, Waltham, Massachusetts...Website
www.fluidformbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About FluidForm Bio
At FluidForm Bio, the company builds living human tissue for better treatment of disease. The company's patented FRESH technology is a revolutionary platform designed to build tissue using cells, proteins, and nothing else. Through partnerships with top life science companies, the company's technology has been validated to produce the highest quality tissue in a variety of applications.Explore more
FluidForm Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is FluidForm Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when FluidForm Bio launches new products
Click to see if FluidForm Bio had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if FluidForm Bio has recently received funding, and reach out quickly before it becomes old news!
Check out if FluidForm Bio is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on FluidForm Bio recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at FluidForm Bio
FluidForm Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once FluidForm Bio has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to FluidForm Bio
Compare insights from companies similar to FluidForm Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
FluidForm Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
FluidForm Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about FluidForm Bio.
FluidForm Bio Tech Stack
A closer look at the technologies used by FluidForm Bio
FluidForm Bio News & Media
FluidForm Bio™ Announces Advance in Bioprinted Tissue Therapies with Landmark Publication in Science Advances
New study establishes CHIPS as a foundation for engineered, vascularized, insulin-producing tissue systems New study establishes CHIPS as a foundation for engineered, vascularized, insulin-producing tissue systemsFluidForm Bio™ Strengthens IP Portfolio with Newly Issued Patent on Key Aspects of its Proprietary FRESH™ Platform
WALTHAM, Mass., April 22, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,215,202 B2, titled, “Additive Manufacturing Support Material.” This newly issued patent expands the foundational intellectual property exclusively licensed to the company from Carnegie Mellon University around FRESH™ (Freeform Reversible Embedding of SuspFluidForm Bio™ Advances Vascularized Tissue Engineering with New FRESH™ 3D Bioprinting Breakthrough
WALTHAM, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced a major advancement in vascularized tissue engineering. A newly published study in ACS Biomaterials Science & Engineering demonstrates how FRESH™ 3D bioprinting, combined with sacrificial gelatin microparticles, significantly enhances cell viability in thick tissue constructs by improving nutrient diffusion and enabling scalable perfusion strFluidForm Bio™ Announces Participation in Venture Summit West
WALTHAM, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced that Mike Graffeo, CEO and co-founder, will deliver a company overview and conduct one-on-one meetings at Venture Summit West, which is being held April 2-3 in Mountain View, CA.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding FluidForm Bio
Sign Up For FreeTo access detailed company insights
At FluidForm Bio, the company builds living human tissue for better treatment of disease. The company's patented FRESH technology is a revolutionary platform designed to build tissue using cells, proteins, and nothing else. Through partnerships with top life science companies, the company's technology has been validated to produce the highest quali... Read More
